Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

导出原文传递

翻译打印收藏纠错

作者： Chiang, Teresa Po-Yu ^[1] ; Connolly, Caoilfhionn M. ^[2] ; Ruddy, Jake A. ^[3] ; Boyarsky, Brian J. ; Alejo, Jennifer L. ; Werbel, William A. ; Massie, Allan ; Chrisopher-Stine, Lisa ; Garonzik-Wang, Jacqueline ; Segev, Dorry L. ; Paik, Julie J.

作者单位： Johns Hopkins Univ, Dept Infect Dis, Baltimore, MD USA ^[1] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21205 USA ^[2] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA ^[3]

发布时间 2021-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Annals of the Rheumatic Diseases

2021年80卷10期

1365-1366页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases

相似文献

Annals of the Rheumatic Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases

相似文献

Annals of the Rheumatic Diseases

相关期刊

检索历史清除